Similac Powder Formula Recall Lawsuit

Similac recall lawsuits are being filed around the country after Abbott Laboratories announced in February a recall of all Similac, Alimentum, and EleCare powdered infant formula products manufactured at the company’s plant in Sturgis, Michigan. Similac PM 60/40 has now also been recalled after a baby exposed to this powdered baby formula died.

Our lawyers are pursuing Similac recall lawsuits in all 50 states.  When the Similac recall was announced, our attorneys were under the impression there would be a handful of serious injury and wrongful death cases from this recall. We were wrong. Our law firm has received hundreds of calls, many of which are from parents whose child has suffered serious injury or death from food poisoning from Similac.

October 1, 2022 Similac Lawsuit Update

There is a new Similac recall class action lawsuit.

The JPML has agreed to consolidate all lawsuits in federal court involving Abbott’s infant formula recall which was traced back to contamination from its plant in Sturgis, Michigan in February 2022.

The new MDL Abbott recall class action lawsuit will include both personal injury cases and consumer class action cases alleging economic loss related to the formula contamination and recall.

Illinois is the epicenter of baby formula lawsuits.  The MDL class action has been assigned to Judge Matthew F. Kennelly in the Northern District of Illinois, which is where Abbott is headquartered.

July 20, 2022 Similac Recall Update

Just 11 days after production finally resumed at its embattled infant formula facility in Sturgis, MI, Abbott was forced to announce on Wednesday that the plant was once again being shut down temporarily.  Abbott can’t seem to do anything right.

This time, the facility is being shut down because torrential rains caused flash flooding at the plant. The plant had spent the last 4 months on the shelf as the FDA investigated bacteria contamination in powdered infant formula.

The Sturgis plant has recently become the focal point of public anger as an acute shortage of baby formula has plagued the U.S. The reopening of the plant 2 weeks ago was fast-tracked in a desperate effort to help alleviate the shortage, but now that will be on hold until the flood damage can be addressed.

July 13, 2022 Similac Recall Update

Just as the embattled baby formula plant in Michigan is finally resuming operations, it is now being reported that a former Abbott employee filed a whistleblower complaint about the facility with OSHA back in February 2021. The complaint reported various concerns about the plant and claimed that records were being falsified. More significantly, it shows that federal authorities were on notice of the problems at the Sturgis, MI facility over a year before those conditions eventually led to a Similac recall and an acute shortage of baby formula.

June 6, 2022 Similac Recall Update

At the end of last week (June 4) the FDA finally allowed production operations to restart at Abbott’s formula manufacturing plant in Sturgis, MI. A dangerous bacteria outbreak was linked to the facility and a subsequent investigation by the FDA identified numerous violations and unsanitary conditions. This prompted an emergency shutdown of the entire plant which lasted several months before operations finally resumed last week.

Infant formula shortages were starting across the U.S. even before the issues at the Michigan facility arose, but the shutdown made things worse and became the focal point of public outrage. The Sturgis facility is being allowed to reopen under the terms of a strict consent decree between Abbott and the FDA.

June 1, 2022 Similac Recall Update

FDA Commissioner Robert Califf was called before Congress last week to testify about the Similac recall and the shutdown of the Abbott formula plant in Michigan.

The shutdown and related Similac recall have played a large part in the acute baby formula shortage that has hit the U.S. this year and captured national attention recently. Commissioner Califf provided lawmakers with the details of the various sanitation deficiencies at the Abbott plant in Michigan that prompted the shutdown.

Califf also admitted that it took his agency several months to respond to the initial whistleblower report that alerted the FDA to the problem.

I have been saying I think the settlement amounts in serious injury and death lawsuits involving the Similac recall will be very high.  This provides further foundation for my prediction on settlement.  Because this was screwed up by everyone.

Does this mean you will see high settlement payouts for insignificant injury Similac recall lawsuits?  No.  But the serious injury and death cases may have very high settlement amounts.

May 3, 2022 Similac Recall Update

One of the plaintiffs who recently filed a Similac recall lawsuit on behalf of his infant daughter is seeking a class action lawsuit.

Her Similac recall lawyer has filed a motion asking the JPML to consolidate all other lawsuits involving the Similac recall into a new mass-tort MDL.

The motion identifies 18 currently pending Similac recall cases in 6 different federal districts.  Sixteen of the eighteen cases are putative class actions that seek to represent the interests of thousands of unidentified infants.

The plaintiffs in these cases allege that their infants developed bacterial infections from the recalled Similac formula.

March 30, 2022 Similac Recall Update

The FDA released a preliminary report detailing the findings of its investigation into the recent contamination of powdered Similac at Abbott’s plant in Michigan.  Not surprisingly, the FDA accuses Abbott of failing to take appropriate steps (such as regularly cleaning surfaces) to prevent product contamination.

Inspectors noted similar deficiencies in previous routine inspections of the Sturgis, Michigan plant where a great deal of Similac was made.  It will issue later more detailed findings and conclusions.

Abbott has issued a statement saying that it has “already begun implementing corrective actions.”  This is not helpful for children who have already suffered from Similac food poisoning.  Nor is the baby formula shortage that this recall has exacerbated.

Cronobacter Sakazakii Bacteria Recall

The recalled products from this facility may be contaminated with Cronobacter sakazakii, a dangerous bacterium that can pose a very serious risk to infants. There have been at least four reported cases of infants being hospitalized as a result of the contaminated formulas.

Our firm is now accepting cases from parents of infants who developed a bacterial infection from consuming contaminated Similac formula.


Related Posts:


FDA Launches Investigation of Cronobacter Contamination in Powdered Formula

On February 17, 2022, the FDA issued a public announcement stating that the administration was investigating possible bacteria contamination in powdered infant formula products manufactured at the Abbott Laboratories plant in Sturgis, Michigan. The powdered infant formula products produced at this facility include Abbott’s flagship brand Similac, and lesser brands EleCare, and Alimentum.

download-28

The investigation was initiated after the FDA received four separate complaints of infants who were hospitalized with Cronobacter sakazakii infections.

All four of the infants in the complaints were infected after consuming powdered baby formula products that were made at the Abbott plant in Michigan. The infected infants came from three different states (Minnesota, Ohio, and Texas) and one of the infants died as a result of complications related to the infection.

The FDA stopped inspecting the Michigan plant during COVID.  When they resumed inspections,  they found evidence of Cronobacter sakazakii.  Alarms went off because we knew this deadly bacteria can survive for years in powdered baby formula.

The FDA public announcement cautioned consumers to avoid purchasing or using any powdered baby formula products that were made at the Sturgis, Michigan plant. FDA investigators are conducting an onsite inspection of the Abbott plant in Michigan and testing environmental samples. This inspection has already found evidence that seems to confirm the presence of Cronobacter contamination at the facility.

Here is a quote from Politico on March 5, 2022, that summarizes this mess:

It’s kind of alarming that we know more about Russian military tactics in Ukraine than we do about FDA’s actions regarding the Abbott facility.

–  Brian Ronholm, Director of Food Policy at Consumer Reports.

Cronobacter Infections Are Hard on Babies

Cronobacter sakazakii (previously known as Enterobacter sakazakii) is a type of bacteria that is found naturally in various environments. Cronobacter is known to thrive in certain dry foods and high-starch mediums such as powdered milk, herbal teas, and powdered infant formulas. In adults, Cronobacter can be a nuisance that triggers intestinal distress, diarrhea, and in some cases urinary tract infections.

For newborns and infants, Cronobacter infections can be very harmful and potentially life-threatening. Infants have underdeveloped gastrointestinal systems that are less able to contain dangerous bacteria. Cronobacter infections in infants (particularly premature infants) can rapidly progress into deadly systemic infections such as sepsis (an infection of the bloodstream) and meningitis (infection involving the brain and spinal cord).

Initial symptoms of Cronobacter infections in babies include fever and refusal to feed often accompanied by lethargy. Cronobacter infections in infants are relatively rare, but when they do occur they are almost always the result of contaminated powdered infant formula. This is because Cronobacter germs can survive in the dry environments of powdered food stores.

Abbott Announces Recall of Powdered Formula Products

A day after the FDA publicly announced its investigation, Abbott Laboratories initiated a “voluntary” recall of all powdered formula products that were made at the company’s Sturgis Michigan facility. The recall covered powdered versions of Abbott’s formula products including Similac, Alimentum, and EleCare formulas.

According to Abbott, the recalled products were distributed across the U.S. and to several other countries around the world. Abbott established a Similac recall website to help consumers determine whether their product is covered by the recall.

Abbott Hardly Surprised by Cronobacter Sakazakii in Formula

No one at Abbott could be stunned about the Cronobacter sakazakii in baby formula. Abbott had already found cronobacter at the plant five times in the last two years. Worse still, this deadly bacteria twice found its way into baby formula.  Abbott did not send those cans out for sale. It pulled those batches out of the distribution chain.  But Abbott did not recall any others and we don’t know exactly what they did to address the problem.

But the whole Michigan plant was a mess.  The FDA found drying equipment with a history of pits and cracks. This is a haven for cronobacter to hide and multiply.

Recall Is More Bad News for Infant Formula Makers

The recent Similac recall due to possible contamination is just the latest in a string of negative events related to Similac and other infant formulas.

Over the last 16 months, Abbott and Mead Johnson (the maker of Enfamil) have been defending a growing number of baby formula lawsuits alleging that they failed to warn that their formulas put premature babies at increased risk of a dangerous infection called necrotizing enterocolitis (NEC). These NEC lawsuits are about to be consolidated into a new class-action lawsuit. Abbott and other manufacturers have also had to deal with supply-chain-related shortages that have made headlines recently.

Similac Recall Class Action Lawsuit

Parents of babies who develop a Cronobacter infection from consuming contaminated Similac from Abbott’s Michigan facility will be entitled to financial compensation for their medical expenses and pain & suffering. A large number of Similac recall lawsuits are expected to be filed which could lead to the formation of a new class-action MDL in which all Similac recall lawsuits in federal court would be consolidated together

The Similac recall lawsuits are now in a class action. These lawsuits will follow a path similar to other mass torts involving recalled consumer products. The Similac recall lawsuits are consolidated before a single judge who would oversee a process of consolidated discovery as additional lawsuits are added to the class action. A few representative cases will be selected for jury trials known as “bellwether” trials. The results of these test trials should then facilitate some type of global settlement in which Abbott agrees to pay a lump sum to resolve all pending cases.

FAQs: Similac Recall

Why was Similac recalled?

Abbott recalled powdered Similac formula products manufactured at its Sturgis, Michigan facility due to a possible Cronobacter contamination at the plant that may be linked to 4 cases of infant hospitalizations. Cronobacter infections can be very dangerous for newborns.

What Similac products were recalled?

Only powdered Similac formula products manufactured at the Abbott facility in Sturgis, MI were recalled. No liquid formula products have been recalled.

How do I know if my Similac has been recalled?

To find out if you powdered Similac formula is covered by the recall, check the lot number on the product and enter on Abbott’s recall website.

Similac Recall Lawsuits Are Lawyers Are Taking

Our lawyers are only handling Similac recall lawsuits if the child

  • Diagnosed with Samonella
  • Diagnosed with Cronbacter
  • Hospitalized or Died

Contact Us About a Contaminated Similac Lawsuit

Our firm is currently seeking Similac recall lawsuits from parents of babies who developed Cronobacter infections from contaminated powdered infant formula. Call us at 800-553-8082 or contact us online for a free case evaluation.

Our baby formula lawyers are also seeking NEC Similac lawsuits from premature infants who were fed Similac and developed necrotizing enterocolitis.

Contact Information